Ciprofloxacin dry powder for inhalation regulatory update

FDA granted Qualified Infectious Disease Product (QIDP) designation to ciprofloxacin dry powder for inhalation (DPI) from Bayer to treat non-cystic fibrosis bronchiectasis. Ciprofloxacin DPI is in Pha...